Olanzapine-based vs neurokinin-1 receptor antagonist antiemetic regimens in highly emetogenic chemotherapy: Systematic review and meta-analysis of efficacy and safety

doi:10.12998/wjcc.v14.i12.119112

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 12

This Article

Google Scholar

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-3)

Sum=42

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=47

Publishing Process of This Article

Item

Count

Browse

Download

Sum=9

Apr 26, 2026 (publication date) through Apr 15, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Cases. Apr 26, 2026; 14(12): 119112
Published online Apr 26, 2026. doi: 10.12998/wjcc.v14.i12.119112

Open in New Tab Full Size Figure Download Figure

Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-analyses flowchart for the review.

Open in New Tab Full Size Figure Download Figure

Figure 2 Risk of bias assessment for randomized control. A: Individual studies using the risks of bias 2.0 tool; B: Overall studies using the risks of bias 2.0 tool.

Open in New Tab Full Size Figure Download Figure

Figure 3 Risk of bias assessment for cohort. A: Individual studies using the risk of bias in nonrandomized studies of interventions version I tool; B: Overall studies using the risk of bias in nonrandomized studies of interventions version I tool.

Open in New Tab Full Size Figure Download Figure

Figure 4 Forest plot. A: Assessment comparing the effectiveness of antagonist antiemetic; B: Assessment comparing the mortality rate - antipsychotic drugs. CI: Confidence interval.

Citation: Mv A, Anand N, Babu B, Awosika A, Udayan U, Mendoza J, Lopez A, Rangachari B, Maity S, Gadad BS. Olanzapine-based vs neurokinin-1 receptor antagonist antiemetic regimens in highly emetogenic chemotherapy: Systematic review and meta-analysis of efficacy and safety. World J Clin Cases 2026; 14(12): 119112
URL: https://www.wjgnet.com/2307-8960/full/v14/i12/119112.htm
DOI: https://dx.doi.org/10.12998/wjcc.v14.i12.119112